
Purpose: Resistance and endurance exercise produce distinct adaptations, but molecular responses that distinguish these exercise modalities across studies and molecular layers remain incompletely defined. We sought to identify reproducible resistance- and endurance-associated molecular responses across human skeletal muscle and plasma omics datasets. Methods: We integrated publicly available human exercise omics datasets. Random-effects meta-analyses included 15,312 genes from three skeletal muscle RNA-seq datasets and 4,641 proteins from two skeletal muscle proteomic datasets. Early skeletal muscle phosphoproteomic responses were compared across two independent studies using 2,430 matched phosphosites. At 24 hours, skeletal muscle phosphoproteomics and targeted and untargeted metabolomics in skeletal muscle and plasma were analyzed separately; plasma proteomics was not analyzed. Effects were standardized as resistance exercise minus endurance exercise, with significance defined within each molecular layer at FDR<0.05. Results: RNA-seq identified 269 genes, including 71 resistance-associated and 198 endurance-associated genes. Global proteomics identified 10 proteins (nine resistance-associated; one endurance-associated). Early phosphoproteomic effects correlated across studies (r=0.589, P=4.1x10 -227 ); 210 of 238 significant phosphosites were directionally concordant, and 51 met replication criteria. At 24 hours, targeted plasma metabolomics identified 14 endurance-associated features, while untargeted plasma metabolomics identified 18 features, including nine resistance-associated and nine endurance-associated features. Resistance-associated responses involved contractile, myofibrillar, cytoskeletal, extracellular matrix, protein quality-control, stress-response, and phosphorylation-related processes. Endurance-associated responses involved mitochondrial oxidative metabolism, respiratory-chain biology, fatty acid oxidation, substrate utilization, amino acid metabolism, and mitochondrial proteostasis. Conclusions: Human molecular responses to resistance and endurance exercise are molecular-layer specific. Endurance-associated responses were more consistently represented in transcriptomic and metabolic layers, whereas resistance-associated responses were more prominent in protein abundance and phosphorylation. These findings provide a quantitative basis for selecting molecular measurements and sampling strategies in future human resistance and endurance exercise studies.
Background: Cardiovascular diseases (CVDs) are leading global causes of mortality and morbidity. Although physical activity (PA) and healthy blood lipid levels are both well-established independent protective factors, their joint associations and potential interactions on the risk of CVDs—including coronary heart disease (CHD), stroke, and a composite of them—remain inadequately studied. We aimed to investigate the joint association of PA and lipid profiles with the risk of CVDs in two large prospective cohorts. Methods: This prospective study leveraged data from two independent large cohorts: the UK Biobank (UKB, N = 230,972), to evaluate associations of PA and blood lipids with CVDs, and the China Kadoorie Biobank (CKB, N = 18,174), to examine associations with stroke. PA was assessed via questionnaire and categorized as inactive, active, or highly active. Blood lipids (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, total cholesterol, apolipoprotein A1, and apolipoprotein B) were classified as high risk, borderline, or ideal. Cox proportional hazards models were used to analyze independent and joint associations between PA and lipids and incident CVDs. Complementary analyses including device-measured PA and polygenic risk scores for lipids were performed. Results: In UKB, participants in the active and highly active groups had a significantly lower risk of incident CVD (active: hazard ratio [HR] 0.94; 95% confidence interval [CI], 0.90–0.98; highly active: HR 0.90; 95% CI, 0.88–0.93; P for trend < 0.001) and CHD events (active: HR 0.92; 95% CI, 0.88–0.96; highly active: HR 0.89; 95% CI, 0.86–0.92; P for trend < 0.001), but no significant association was observed for stroke ( P for trend = 0.244). In CKB, higher PA was significantly associated with lower stroke risk (active: HR 0.79; 95% CI, 0.69–0.91; highly active: HR 0.66; 95% CI, 0.60–0.74; P for trend < 0.001), consistent with the protective effects observed for favorable lipid profiles. No significant multiplicative interactions between PA and lipids were detected. However, joint analyses showed a graded reduction in risk and participants who were highly active or had ideal lipid levels had the lowest cardiovascular risk. Complementary analyses reinforced the results. Conclusion: Targeting both PA and lipid profiles is important for cardiovascular health, as these factors may exert complementary and partially independent effects on cardiovascular risk. Accordingly, improvements in either PA or lipid profiles may confer additional cardiovascular benefits, even among individuals with favorable levels of the other factor.
Purpose: Investigate predictors of failure and injury during British Army basic training and test the performance of statistical learning models to predict these outcomes. Methods: 968 male and 450 female recruits had demographics, lifestyle habits, mood, physical performance, body composition, micronutrient status, and bone metabolism measured at week 1 of training. Associations between predictors and training outcome (failure; lower limb overuse musculoskeletal injury) were assessed by logistic regression. Training outcome was predicted by logistic regression, elastic net, random forests, and gradient boosting. Results: 66% of men and 76% of women passed with 20% and 34% developing an injury. For men, slower 2.4 km run time (odds ratio [OR]=1.004, p=0.011) and higher symptoms of depression (OR=1.173, p=0.001) were associated with higher risk of failing, and lower areal bone mineral density (OR=0.008, p=0.002), slower 2.4 km run time (OR=1.006, p=0.011), previous stress fracture (OR=3.267, p=0.002), lower parathyroid hormone (OR=0.783, p=0.009), and lower c-telopeptide cross-links of type I collagen (βCTX) (OR=0.255, p=0.041) were associated with higher risk of injury. For women, slower 2.4 km run time (OR=1.009, p=0.009) and higher total 25-hydroxyvitamin-D (OR=1.013, p=0.001) were associated with higher risk of failing, and slower 2.4 km run time (OR=1.007, p=0.009), higher alcohol intake (OR=1.006, p=0.017), and lower βCTX (OR=0.057, p=0.026) were associated with higher risk of injury. Training outcome was poorly predicted in men and women (area under the receiver operating characteristic curve≤0.68). All models had low sensitivity and high specificity, but application of an outcome-specific threshold determined using the Youden Index improved sensitivity. Conclusions: Interventions to improve military training outcome should address aerobic fitness prior to starting training. Prediction models may be useful in identifying some ‘at-risk’ recruits.
Masters athletes are individuals ≥35 yr of age who place a high premium on exercise training and competition. This document details important cardiovascular conditions, risk factors, and data-driven discussion, which serve as the rationale for Section X from the 2025 AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes Cardiovascular Abnormalities. Disease-specific risk stratification and shared decision-making are the cornerstones for Masters athletes when considering competitive sports participation. Coronary artery disease, atrial fibrillation, incidental myocardial fibrosis, aortic enlargement and aneurysms, and valvular heart disease are included in this Task Force document.
This document outlines recommendations for managing competitive athletes with arrhythmias and risks of sudden cardiac arrest, emphasizing individualized risk assessment, shared decision-making, and return-to-play protocols tailored to each athlete’s cardiac profile and sport demands. It provides evaluation strategies for ventricular arrhythmias, implantable cardiac defibrillators, atrial fibrillation, supraventricular tachycardia, Wolff–Parkinson–White pattern/syndrome, and syncope, alongside guidance for electrocardiogram interpretation in athletes. A key focus is placed on differentiating between low-risk and high-risk conditions, with recommendations for treatment strategies and ongoing monitoring to ensure athletes’ safety.